Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Nov;51(10):847-854.
doi: 10.1310/hpj5110-847.

Defibrotide

Danial E Baker, Kendra Demaris

Defibrotide

Danial E Baker et al. Hosp Pharm. 2016 Nov.

Abstract

Each month, subscribers to The Formulary Monograph Service receive 5 to 6 well-documented monographs on drugs that are newly released or are in late phase 3 trials. The monographs are targeted to Pharmacy & Therapeutics Committees. Subscribers also receive monthly 1-page summary monographs on agents that are useful for agendas and pharmacy/nursing in-services. A comprehensive target drug utilization evaluation/medication use evaluation (DUE/MUE) is also provided each month. With a subscription, the monographs are are available online to subscribers. Monographs can be customized to meet the needs of a facility. Through the cooperation of The Formulary, Hospital Pharmacy publishes selected reviews in this column. For more information about The Formulary Monograph Service, contact Wolters Kluwer customer service at 866-397-3433. The November 2016 monograph topics are apaziquone, crisaborole, irinotecan liposome, plecanatide, and telotristat. The Safety MUE is on methylnaltrexone PO.

PubMed Disclaimer

References

    1. Defitelio (defibrotide sodium) [prescribing information]. Palo Alto, CA: Jazz Pharmaceuticals; March 2016.
    1. Coppell JA, Richardson PG, Soiffer R. et al. Hepatic veno-occlusive disease following stem cell transplantation: Incidence, clinical course, and outcome. Biol Blood Marrow Transplant. 2010; 16( 2): 157– 168. - PMC - PubMed
    1. Platzbecker U, Bornhäuser M. SOS for veno-occlusive disease: Defibrotide prophylaxis. Lancet. 2012; 379( 9823): 1277– 1278. - PubMed
    1. Zhang L, Wang Y, Huang H. Defibrotide for the prevention of hepatic veno-occlusive disease after hematopoietic stem cell transplantation: A systematic review. Clin Transplant. 2012; 26( 4): 511– 519. - PubMed
    1. Hopps SA, Borders EB, Hagemann TM. Prophylaxis and treatment recommendations for sinusoidal obstruction syndrome in adult and pediatric patients undergoing hematopoietic stem cell transplant: A review of the literature [published online ahead of print June 30, 2015]. J Oncol Pharm Pract. 2016; 22( 3): 496– 510. - PubMed